Artificial Intelligence for Alzheimer’s Disease Diagnosis: From Traditional Machine Learning to Large Language Models
Biosensors · 2026
DOI: 10.3390/bios16090514 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biosensors, 2026. Verfasst von Xiayao Guo und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Digital Medical Engineering, School of Biological Science and Medical Engineering, Southeast University, Nanjing 210096, Chin…. Hauptthemen laut MEDLINE: Alzheimer Disease, Machine Learning, Artificial Intelligence. Die Arbeit nennt 173 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Alzheimer’s disease (AD) is the most prevalent neurodegenerative disorder and a leading cause of dementia worldwide, characterized by progressive cognitive decline, memory impairment, and functional deterioration. With the rapid growth of the aging population, AD has become a major global health challenge, imposing substantial burdens on patients, families, and healthcare systems. Despite extensive research, early and accurate diagnosis of AD remains challenging due to disease heterogeneity, overlapping clinical manifestations, and the lack of easily accessible, highly sensitive, and specific diagnostic markers. Recent advances in biomedical technologies, including neuroimaging, multi-omics profiling, electronic health records, and digital health tools, have generated large-scale and heterogeneous datasets, providing new opportunities for improving AD diagnosis. However, extracting clinically meaningful information from these complex data sources remains difficult using conventional statistical approaches. Artificial intelligence (AI) has progressively transformed AD diagnosis by evolving from traditional machine learning (ML) approaches based on handcrafted feature engineering to deep learning (DL) models capable of automated representation learning and multimodal information integration. More recently, large language models (LLMs) have further expanded the scope of AI-driven AD diagnosis by enabling contextual understanding of unstructured clinical information, knowledge-guided reasoning, and integration of multimodal biomedical evidence. This transition reflects a shift from feature-based prediction toward more flexible and intelligent diagnostic frameworks. This review synthesizes recent advances in AI-based AD diagnosis, tracing the evolution from traditional ML to DL and LLMs. Particular emphasis is placed on the emerging role of LLMs in extracting disease-related information from speech and clinical narratives, integrating heterogeneous biomedical data sources, and enabling multimodal frameworks for AD assessment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Digital Medical Engineering, School of Biological Science and Medical Engineering, Southeast University, Nanjing 210096, China.
- School of Computer Science and Engineering, Southeast University, Nanjing 210096, China.
ORCID-Profile: Hongde Liu, Xuemei Wang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Guo, X., Sun, Y., Chen, Y., Liu, H., Liu, X., & Wang, X. (2026). Artificial Intelligence for Alzheimer’s Disease Diagnosis: From Traditional Machine Learning to Large Language Models. Biosensors. https://doi.org/10.3390/bios16090514
Vancouver
Guo X, Sun Y, Chen Y, Liu H, Liu X, Wang X. Artificial Intelligence for Alzheimer’s Disease Diagnosis: From Traditional Machine Learning to Large Language Models. Biosensors. 2026. doi:10.3390/bios16090514
BibTeX
@article{Guo2026,
author = {Guo, Xiayao and Sun, Yanqi and Chen, Yang and Liu, Hongde and Liu, Xiaohui and Wang, Xuemei},
title = {Artificial Intelligence for Alzheimer’s Disease Diagnosis: From Traditional Machine Learning to Large Language Models},
journal = {Biosensors},
year = {2026},
doi = {10.3390/bios16090514}
}
EUVIMED